Please enable JavaScript to continue using this application.

Compare $PTCT vs $SRRK | Chartloom

Compare

$PTCT vs $SRRK

PTC Therapeutics Inc · Scholar Rock Holding Corp

PTCT

PTC Therapeutics Inc

SRRK

Scholar Rock Holding Corp

Compare $PTCT vs $SRRK

Comparing PTC Therapeutics Inc and Scholar Rock Holding Corp

PTCTPTC Therapeutics Inc

SRRKScholar Rock Holding Corp

PTCTPTC Therapeutics Inc

Market cap

$5.37B

P/E (TTM)

—

Forward P/E (NTM)

43.00x

Forward P/S (NTM)

4.18x

Rev growth (TTM)

-36.7%

YTD performance

-15.7%

52W performance

0.3%

FCF yield

-0.7%

SRRKScholar Rock Holding Corp

Market cap

$5.06B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

122.55x

Rev growth (TTM)

—

YTD performance

-1.4%

52W performance

9.0%

FCF yield

-5.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

PTCT

SRRK

Detailed metrics comparison

PTCT

PTC Therapeutics Inc

SRRK

Scholar Rock Holding Corp

Market Cap

PTCT$5.37B

SRRK$5.06B

Enterprise Value

PTCT$7.24B

SRRK$4.81B

Price

PTCT$64.70

SRRK$42.19

P/E Ratio

PTCTN/A

SRRKN/A

P/S Ratio

PTCT5.32x

SRRK120.52x

EV/Sales

PTCT7.17x

SRRK115.43x

EV/EBITDA

PTCT35.21x

SRRK0.00x

P/B Ratio

PTCT3,530.95x

SRRK22.46x

P/FCF Ratio

PTCTN/A

SRRKN/A

EV/FCF

PTCT-182.20x

SRRK-16.21x

PEG Ratio

PTCTN/A

SRRKN/A

Forward P/E (NTM)

PTCT43.00x

SRRKN/A

Forward P/S (NTM)

PTCT4.18x

SRRK122.55x

Revenue (TTM)

PTCT$1.01B

SRRK$0

Revenue Growth (YoY)

PTCT-36.7%

SRRKN/A

Forward Rev Growth

PTCT11.6%

SRRK2628.0%

Gross Margin (TTM)

PTCT93.0%

SRRK0.0%

Operating Margin (TTM)

PTCT12.4%

SRRK0.0%

EBITDA Margin (TTM)

PTCT17.1%

SRRK0.0%

Net Margin (TTM)

PTCT-3.8%

SRRK0.0%

FCF Margin (TTM)

PTCT-3.9%

SRRKN/A

Net Income (TTM)

PTCT$-38M

SRRK$-406M

FCF (TTM)

PTCT$-40M

SRRK$-297M

EPS (TTM)

PTCT-$0.42

SRRK-$3.11

ROE (TTM)

PTCT-35191.0%

SRRK-15912.0%

ROA (TTM)

PTCT-132.0%

SRRK-8660.0%

ROIC (TTM)

PTCT-3977.0%

SRRK-10069.0%

Cash

PTCT$1.05B

SRRK$437M

Debt

PTCT$2.92B

SRRK$196M

Net Cash/Debt

PTCT$-1.87B

SRRK$241M

Current Ratio (TTM)

PTCT3.39x

SRRK7.02x

Quick Ratio (TTM)

PTCT3.20x

SRRK6.84x

Debt/Equity (TTM)

PTCT848.93x

SRRK0.77x

Debt/Assets (TTM)

PTCT0.0%

SRRK0.0%

Interest Coverage (TTM)

PTCTN/A

SRRKN/A

Net Debt/EBITDA (TTM)

PTCT0.00x

SRRK0.00x

Beta

PTCT0.50

SRRK0.76

52W Performance

PTCT0.3%

SRRK9.0%

YTD Performance

PTCT-15.7%

SRRK-1.4%

% from 52W High

PTCT-28.8%

SRRK-31.7%

% from 52W Low

PTCT5.7%

SRRK55.9%

Asset Turnover (TTM)

PTCT0.35x

SRRK0.16x

FCF Yield (TTM)

PTCT-0.7%

SRRK-5.9%

Earnings Yield (TTM)

PTCT-0.7%

SRRK-8.0%

Dividend Yield (TTM)

PTCTN/A

SRRKN/A

Rule of 40

PTCT-40.7

SRRK0.0

EV/GP/RG

PTCT0.24

SRRKN/A

Ticker research

View PTCT research View SRRK research

Metric	PTCT PTC Therapeutics Inc	SRRK Scholar Rock Holding Corp
Market & Valuation
Market Cap	$5.37B	$5.06B
Enterprise Value	$7.24B	$4.81B
Price	$64.70	$42.19
P/E Ratio	N/A	N/A
P/S Ratio	5.32x	120.52x
EV/Sales	7.17x	115.43x
EV/EBITDA	35.21x	0.00x
P/B Ratio	3,530.95x	22.46x
P/FCF Ratio	N/A	N/A
EV/FCF	-182.20x	-16.21x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	43.00x	N/A
Forward P/S (NTM)	4.18x	122.55x
Revenue & Growth
Revenue (TTM)	$1.01B	$0
Revenue Growth (YoY)	-36.7%	N/A
Forward Rev Growth	11.6%	2628.0%
Profitability
Gross Margin (TTM)	93.0%	0.0%
Operating Margin (TTM)	12.4%	0.0%
EBITDA Margin (TTM)	17.1%	0.0%
Net Margin (TTM)	-3.8%	0.0%
FCF Margin (TTM)	-3.9%	N/A
Net Income (TTM)	$-38M	$-406M
FCF (TTM)	$-40M	$-297M
EPS (TTM)	-$0.42	-$3.11
ROE (TTM)	-35191.0%	-15912.0%
ROA (TTM)	-132.0%	-8660.0%
ROIC (TTM)	-3977.0%	-10069.0%
Financial Health
Cash	$1.05B	$437M
Debt	$2.92B	$196M
Net Cash/Debt	$-1.87B	$241M
Current Ratio (TTM)	3.39x	7.02x
Quick Ratio (TTM)	3.20x	6.84x
Debt/Equity (TTM)	848.93x	0.77x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.50	0.76
52W Performance	0.3%	9.0%
YTD Performance	-15.7%	-1.4%
% from 52W High	-28.8%	-31.7%
% from 52W Low	5.7%	55.9%
Efficiency & Yields
Asset Turnover (TTM)	0.35x	0.16x
FCF Yield (TTM)	-0.7%	-5.9%
Earnings Yield (TTM)	-0.7%	-8.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-40.7	0.0
EV/GP/RG	0.24	N/A
Ticker research	View PTCT research	View SRRK research

Valuation

P/S Ratio

PTCT

5.32x

SRRK

120.52x

EV/FCF

PTCT

-182.20x

SRRK

-16.21x

Growth & revenue

Revenue Growth TTM

PTCT

-36.7%

Forward Revenue Growth

SRRK

2628.0%

PTCT

11.6%

Profitability & performance

Gross Margin

PTCT

93.0%

SRRK

0.0%

ROE

SRRK

-15912.0%

PTCT

-35191.0%

FCF Yield %

PTCT

-0.7%

SRRK

-5.9%

52-Week Performance

SRRK

9.0%

PTCT

0.3%

Detailed metrics comparison

PTCT

PTC Therapeutics Inc

SRRK

Scholar Rock Holding Corp

Market Cap

PTCT$5.37B

SRRK$5.06B

Enterprise Value

PTCT$7.24B

SRRK$4.81B

Price

PTCT$64.70

SRRK$42.19

P/E Ratio

PTCTN/A

SRRKN/A

P/S Ratio

PTCT5.32x

SRRK120.52x

EV/Sales

PTCT7.17x

SRRK115.43x

EV/EBITDA

PTCT35.21x

SRRK0.00x

P/B Ratio

PTCT3,530.95x

SRRK22.46x

P/FCF Ratio

PTCTN/A

SRRKN/A

EV/FCF

PTCT-182.20x

SRRK-16.21x

PEG Ratio

PTCTN/A

SRRKN/A

Forward P/E (NTM)

PTCT43.00x

SRRKN/A

Forward P/S (NTM)

PTCT4.18x

SRRK122.55x

Revenue (TTM)

PTCT$1.01B

SRRK$0

Revenue Growth (YoY)

PTCT-36.7%

SRRKN/A

Forward Rev Growth

PTCT11.6%

SRRK2628.0%

Gross Margin (TTM)

PTCT93.0%

SRRK0.0%

Operating Margin (TTM)

PTCT12.4%

SRRK0.0%

EBITDA Margin (TTM)

PTCT17.1%

SRRK0.0%

Net Margin (TTM)

PTCT-3.8%

SRRK0.0%

FCF Margin (TTM)

PTCT-3.9%

SRRKN/A

Net Income (TTM)

PTCT$-38M

SRRK$-406M

FCF (TTM)

PTCT$-40M

SRRK$-297M

EPS (TTM)

PTCT-$0.42

SRRK-$3.11

ROE (TTM)

PTCT-35191.0%

SRRK-15912.0%

ROA (TTM)

PTCT-132.0%

SRRK-8660.0%

ROIC (TTM)

PTCT-3977.0%

SRRK-10069.0%

Cash

PTCT$1.05B

SRRK$437M

Debt

PTCT$2.92B

SRRK$196M

Net Cash/Debt

PTCT$-1.87B

SRRK$241M

Current Ratio (TTM)

PTCT3.39x

SRRK7.02x

Quick Ratio (TTM)

PTCT3.20x

SRRK6.84x

Debt/Equity (TTM)

PTCT848.93x

SRRK0.77x

Debt/Assets (TTM)

PTCT0.0%

SRRK0.0%

Interest Coverage (TTM)

PTCTN/A

SRRKN/A

Net Debt/EBITDA (TTM)

PTCT0.00x

SRRK0.00x

Beta

PTCT0.50

SRRK0.76

52W Performance

PTCT0.3%

SRRK9.0%

YTD Performance

PTCT-15.7%

SRRK-1.4%

% from 52W High

PTCT-28.8%

SRRK-31.7%

% from 52W Low

PTCT5.7%

SRRK55.9%

Asset Turnover (TTM)

PTCT0.35x

SRRK0.16x

FCF Yield (TTM)

PTCT-0.7%

SRRK-5.9%

Earnings Yield (TTM)

PTCT-0.7%

SRRK-8.0%

Dividend Yield (TTM)

PTCTN/A

SRRKN/A

Rule of 40

PTCT-40.7

SRRK0.0

EV/GP/RG

PTCT0.24

SRRKN/A

Ticker research

View PTCT research View SRRK research

Metric	PTCT PTC Therapeutics Inc	SRRK Scholar Rock Holding Corp
Market & Valuation
Market Cap	$5.37B	$5.06B
Enterprise Value	$7.24B	$4.81B
Price	$64.70	$42.19
P/E Ratio	N/A	N/A
P/S Ratio	5.32x	120.52x
EV/Sales	7.17x	115.43x
EV/EBITDA	35.21x	0.00x
P/B Ratio	3,530.95x	22.46x
P/FCF Ratio	N/A	N/A
EV/FCF	-182.20x	-16.21x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	43.00x	N/A
Forward P/S (NTM)	4.18x	122.55x
Revenue & Growth
Revenue (TTM)	$1.01B	$0
Revenue Growth (YoY)	-36.7%	N/A
Forward Rev Growth	11.6%	2628.0%
Profitability
Gross Margin (TTM)	93.0%	0.0%
Operating Margin (TTM)	12.4%	0.0%
EBITDA Margin (TTM)	17.1%	0.0%
Net Margin (TTM)	-3.8%	0.0%
FCF Margin (TTM)	-3.9%	N/A
Net Income (TTM)	$-38M	$-406M
FCF (TTM)	$-40M	$-297M
EPS (TTM)	-$0.42	-$3.11
ROE (TTM)	-35191.0%	-15912.0%
ROA (TTM)	-132.0%	-8660.0%
ROIC (TTM)	-3977.0%	-10069.0%
Financial Health
Cash	$1.05B	$437M
Debt	$2.92B	$196M
Net Cash/Debt	$-1.87B	$241M
Current Ratio (TTM)	3.39x	7.02x
Quick Ratio (TTM)	3.20x	6.84x
Debt/Equity (TTM)	848.93x	0.77x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.50	0.76
52W Performance	0.3%	9.0%
YTD Performance	-15.7%	-1.4%
% from 52W High	-28.8%	-31.7%
% from 52W Low	5.7%	55.9%
Efficiency & Yields
Asset Turnover (TTM)	0.35x	0.16x
FCF Yield (TTM)	-0.7%	-5.9%
Earnings Yield (TTM)	-0.7%	-8.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-40.7	0.0
EV/GP/RG	0.24	N/A
Ticker research	View PTCT research	View SRRK research